Correlation Between Joint Stock and Serina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Joint Stock and Serina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Joint Stock and Serina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Joint Stock and Serina Therapeutics, you can compare the effects of market volatilities on Joint Stock and Serina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Joint Stock with a short position of Serina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Joint Stock and Serina Therapeutics.

Diversification Opportunities for Joint Stock and Serina Therapeutics

-0.21

Correlation Coefficient

Joint Stock  Serina Therapeutics

Very good diversification

The 3 months correlation between Joint and Serina is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Joint Stock and Serina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serina Therapeutics and Joint Stock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Joint Stock are associated (or correlated) with Serina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serina Therapeutics has no effect on the direction of Joint Stock i.e., Joint Stock and Serina Therapeutics go up and down completely randomly.

Pair Corralation between Joint Stock and Serina Therapeutics

Given the investment horizon of 90 days Joint Stock is expected to under-perform the Serina Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Joint Stock is 5.1 times less risky than Serina Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Serina Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  500.00  in Serina Therapeutics on September 20, 2024 and sell it today you would earn a total of  113.00  from holding Serina Therapeutics or generate 22.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Joint Stock  vs.  Serina Therapeutics

Joint Stock

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Joint Stock are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Joint Stock is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Serina Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Serina Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Joint Stock and Serina Therapeutics

The main advantage of trading using opposite Joint Stock and Serina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Joint Stock position performs unexpectedly, Serina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will offset losses from the drop in Serina Therapeutics' long position.

The idea behind Joint Stock and Serina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.